NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that its fourth quarter revenues fell 1 percent year over year on lower assay sales.

Total revenues for the three months ended Dec. 31, 2013, were $55.2 million, down from $55.5 million in the fourth quarter of 2012. The results fell short of the consensus Wall Street estimate of $56.6 million in revenues for the quarter.

By segment, assays and related product revenue fell 25 percent to $19.5 million from $25.9 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.